Chromopharmacology. The efficacy of bupivacaine for blocking nerve conduction does not depend on time of day

被引:0
|
作者
Holthusen, H
Klement, W
Lipfert, P
机构
来源
ANAESTHESIST | 1997年 / 46卷 / 07期
关键词
bupivacaine; chronopharmacology; nerve activity; rabbit;
D O I
10.1007/s001010050441
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
To test the hypothesis that the efficacy of local anaesthetics to block nerve conduction is related the time of day (TOD) of drug application,we retrospectively analysed data from previous experiments on tachyphylaxis. During the course of these experiments, as a measure of drug efficacy we determined the minimal blocking concentration (c(m)) of bupivacaine in rabbit aortic nerves at several TODs. The special in situ preparation used permitted study of local anaesthetic pharmacodynamics without the influence of pharmacokinetics, making it possible to investigate the chronopharmacodynamics of these drugs by relating c(m)s to the respective TODs of their measurement. Methods: In 43 New Zealand rabbits anaesthetised with urethane, the aortic nerve was dissected and partly placed in a double-lumen perfusion chamber (Fig. 1A),which was continuously perifused with tyrode solution or bupivacaine. Spike activity was continuously recorded by bipolar platinum-iridium electrodes caudad to the chamber for control and cephalad for registration of blocking effects. As a measure of drug efficacy, by increasing the bupivacaine concentration stepwise we determined the smallest concentration that blocks spike activity, i.e., c(m). After each determination bupivacaine was rinsed off to confirm intact nerve function (Fig. 1B). Results: Forty-nine determinations of bupivacaine c(m) were performed between 12:25 p.m. and 2:35 a.m. Data were pooled into groups of 2 h (Fig. 2). There was no significant difference between groups (ANOVA). In particular, c(m) at 3:00 p.m. was not lower than at 11:00 p.m., times at which local anaesthetics have been found to be most and least effective, respectively. Conclusions: The c(m) of bupivacaine, and thus its efficacy to block nerve conduction, does not depend on TOD of drug application. Therefore, it is suggested that chronopharmacodynamics does not play an important role in the well-known circadian rhythm of the action of bupivacaine and probably of local anaesthetics in general.
引用
收藏
页码:588 / 591
页数:4
相关论文
共 5 条
  • [1] Chromopharmacology. The efficacy of bupivacaine for blocking nerve conduction does not depend on time of day [Chronopharmakologie. Tageszeitabhangige Schwankungen in der Wirksamkeit von Bupivacain manifestieren sich nicht am Nerven]
    Holthusen H.
    Klement W.
    Lipfert P.
    Der Anaesthesist, 1997, 46 (7) : 588 - 591
  • [2] DOES TRANSIENT BLOCKING OF NERVE-CONDUCTION OCCUR IN UREMIC NEUROPATHY
    MEYER, D
    LANG, AH
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1977, 43 (04): : 617 - 617
  • [3] Does Tinnitus Depend on Time-of-Day? An Ecological Momentary Assessment Study with the "TrackYourTinnitus" Application
    Probst, Thomas
    Pryss, Rudiger C.
    Langguth, Berthold
    Rauschecker, Josef P.
    Schobel, Johannes
    Reichert, Manfred
    Spiliopoulou, Myra
    Schlee, Winfried
    Zimmermann, Johannes
    FRONTIERS IN AGING NEUROSCIENCE, 2017, 9
  • [4] Does the time-of-day administration of immune checkpoint inhibitors affect efficacy in patients with metastatic renal cell carcinoma? A single-center study.
    Fernandez-Manas, Laia
    Gonzalez Aguado, Laura
    Aversa, Caterina
    Ferrer-Mileo, Laura
    Garcia de Herreros, Marta
    Jimenez, Natalia
    Febrer, Albert
    Vernet, Roger
    Garcia-Esteve, Samuel
    Mellado, Begona
    Reig Torras, Oscar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [5] Insulin degludec does not compromise efficacy or safety when given in a flexible once-daily dosing regimen compared to insulin glargine once daily at the same time each day in type 2 diabetes
    Atkin, S. L.
    Bain, S. C.
    Gough, S.
    Shestakova, M. V.
    Raz, I.
    Blonde, L.
    Meneghini, L.
    Begtrup, K.
    Johansen, T.
    Birkeland, K. I.
    DIABETOLOGIA, 2011, 54 : S53 - S53